Gaush Innovation Technology Co., Ltd. has been honored with the "Ophthalmic Application Innovation Award" as part of the 2026 Global Medical Technology Awards.

The 2026 Global Medical Technology Series Awards were announced concurrently. Gaush Innovation Technology Co., Ltd. stood out among numerous participating enterprises, winning the prestigious "Ophthalmic Application Innovation Award" at the conference, in recognition of its outstanding technological innovation achievements and exceptional clinical application value in the ophthalmic field. This award focuses on the real‑world clinical value of innovative products, technologies, and services, honoring representative companies and institutions that have proposed innovative solutions to clinical pain points and achieved positive outcomes in improving diagnostic and treatment efficiency, enhancing patient benefits, and optimizing medical services. It carries a high level of industry authority and credibility.

The company's self‑developed T3 series of corneal confocal microscopes addresses the need for in‑vivo cellular‑level imaging of the cornea, achieving a technical balance between wide field of view and high resolution. By employing laser light source and tomographic confocal scanning technology, the product enables high‑resolution imaging over a relatively large scanning field, allowing observation of the cellular structures of all layers of the living cornea.